KBC Group NV - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
KBC Group NV ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1470.0%3,6650.0%0.00%0.0%
Q2 2023$147
-6.4%
3,665
-4.9%
0.00%0.0%
Q1 2023$157
-23.4%
3,8520.0%0.00%0.0%
Q4 2022$205
-99.9%
3,8520.0%0.00%0.0%
Q3 2022$205,000
-8.9%
3,8520.0%0.00%0.0%
Q2 2022$225,000
+82.9%
3,852
+138.2%
0.00%
Q1 2022$123,000
+26.8%
1,6170.0%0.00%
Q4 2021$97,000
+6.6%
1,6170.0%0.00%
Q3 2021$91,000
-53.6%
1,617
-50.0%
0.00%
Q2 2021$196,000
-13.3%
3,2340.0%0.00%
Q1 2021$226,000
-78.8%
3,2340.0%0.00%
Q4 2020$1,065,000
+449.0%
3,2340.0%0.00%
-100.0%
Q3 2020$194,000
+173.2%
3,234
+46.9%
0.00%0.0%
Q4 2016$71,000
-95.5%
2,201
-95.2%
0.00%
-94.4%
Q3 2016$1,562,000
+9088.2%
45,655
+8834.4%
0.02%
Q2 2016$17,000
-97.2%
511
-95.6%
0.00%
-100.0%
Q1 2016$611,000
-71.6%
11,536
-58.8%
0.01%
-75.0%
Q4 2015$2,152,000
+5148.8%
28,024
+2685.7%
0.04%
+3900.0%
Q3 2015$41,000
-80.8%
1,006
-66.8%
0.00%
-66.7%
Q2 2015$214,000
-94.3%
3,027
-92.8%
0.00%
-93.8%
Q1 2015$3,761,000
+50.6%
42,329
+50.3%
0.05%
+60.0%
Q4 2014$2,498,000
+256.3%
28,170
+289.4%
0.03%
+25.0%
Q3 2014$701,000
-83.7%
7,234
-84.5%
0.02%
-51.0%
Q2 2014$4,294,000
+75.2%
46,746
+33.5%
0.05%
+25.6%
Q1 2014$2,451,00035,0200.04%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders